Latest news
{{'Fri, 15 Aug 2025 17:30:00 -0400' | dateFormatUsFilter}}
Wegovy® approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis
Read more
{{'Wed, 06 Aug 2025 06:35:00 -0400' | dateFormatUsFilter}}
Novo Nordisk's sales increased by 16% in Danish kroner and by 18% at constant exchange rates to USD 22.7 billion in the first six months of 2025
Read more
{{'Tue, 05 Aug 2025 14:00:00 -0400' | dateFormatUsFilter}}
Novo Nordisk expands legal action to protect US patients from unsafe, non-FDA-approved compounded "semaglutide"
Read more
Latest on compounded and counterfeit products and other important information about semaglutide.
Career opportunities
Here are our current job openings. If we don’t currently have an opening in your area of interest, we encourage you to create a job agent and candidate profile.